A randomized, evaluator-blind, phase 2 study comparing the safety and efficacy of omadacycline to those of linezolid for treatment of complicated skin and skin structure infections
about
Antibiotic therapy for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in non surgical woundsThe Novel Aminomethylcycline Omadacycline Has High Specificity for the Primary Tetracycline-Binding Site on the Bacterial RibosomeIn vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcyclineStructure-activity relationship of the aminomethylcyclines and the discovery of omadacycline.In Vitro and In Vivo Assessments of Cardiovascular Effects with Omadacycline.Systematic Review and Meta-Analysis To Estimate Antibacterial Treatment Effect in Acute Bacterial Skin and Skin Structure Infection.Pipeline of Known Chemical Classes of Antibiotics.Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administration of Omadacycline to Healthy Subjects.Effect of Food on the Bioavailability of Omadacycline in Healthy Participants.Omadacycline: development of a novel aminomethylcycline antibiotic for treating drug-resistant bacterial infections.New pharmacological treatments for methicillin-resistant Staphylococcus aureus infections.Current and emerging drugs for acute bacterial skin and skin structure infections: an update.Natural product and natural product derived drugs in clinical trials.An update on emerging therapies for urinary tract infections.Tetracycline Antibiotics and Resistance.Structural characterization of an alternative mode of tigecycline binding to the bacterial ribosome.Pharmacokinetics, Distribution, Metabolism, and Excretion of Omadacycline following a Single Intravenous or Oral Dose of 14C-Omadacycline in Rats.Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult Subjects.Surveillance of Omadacycline Activity against Clinical Isolates from a Global Collection (North America, Europe, Latin America, Asia-Western Pacific), 2010-2011.Activities of Omadacycline and Comparator Agents against Staphylococcus aureus Isolates from a Surveillance Program Conducted in North America and Europe.Once-Daily Treatments for Methicillin-Susceptible Staphylococcus aureus Bacteremia: Are They Good Enough?Efficacy and safety of linezolid compared with other treatments for skin and soft-tissue infections: a meta-analysis.Omadacycline: comparative in vitro activity against dog and cat bite wound isolates.Clinical disposition, metabolism and in vitro drug-drug interaction properties of omadacycline.
P2860
Q24202424-D5126003-11C9-4F33-B429-C2F956535340Q28818623-5B2B5EB3-748A-4C29-8D93-846D07A69873Q34389235-53B60D99-7BF8-4A94-90EF-84669AD379BBQ34493150-BB3DB361-F2F2-4300-A2A0-A448023F9C21Q34531473-41254899-77A7-4D42-A9FF-D62BD0D243E5Q35860102-E9ACCC98-5C1D-4450-A09E-524CD36B2357Q36683409-BB0AC70F-05A9-40FB-A5A3-9210D0614659Q37428710-616131D1-2BF5-4F21-AF48-47303DC313E2Q37664108-F350453E-56C3-4BB3-A0B8-B35DCE64C79DQ37835462-74FDF837-FB41-465B-B454-F014C8EA2C8DQ38179460-A0B51A4D-650A-4BA1-A771-6F8EDD9BB212Q38242081-D4C7D74C-48B0-4575-AA3B-665DA8D54DA3Q38247457-0692BB9B-634F-472C-B3D6-61F81E87BF05Q38751454-BC528CD8-ADF1-480C-831C-D035BD98B862Q38779243-4AB80392-17F3-45EA-B763-C54E63991EA2Q39564833-FC8E7F5D-02E5-4ACB-B504-CD80A6C8E250Q40035130-3EDD8D3A-7A14-4932-8798-F0D910BF69E0Q40140013-70EF8397-E6DC-4934-A01A-04692E0BC9E7Q40323052-3EED299A-F8F3-44C2-A4AC-D6ECD7A67932Q40403783-41613825-2D27-4163-9579-812FC968A758Q41994740-2A86E71A-09AB-49F1-B108-3C732EF7D774Q47327608-EF63B656-3D6D-460C-8757-E3FAC6D37404Q50028177-594257D4-ADD0-4667-9AA0-A789A21C09F1Q51587016-9AD3C96C-4D92-4D51-A895-5AD75DDE619C
P2860
A randomized, evaluator-blind, phase 2 study comparing the safety and efficacy of omadacycline to those of linezolid for treatment of complicated skin and skin structure infections
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A randomized, evaluator-blind, ...... and skin structure infections
@ast
A randomized, evaluator-blind, ...... and skin structure infections
@en
A randomized, evaluator-blind, ...... and skin structure infections
@nl
type
label
A randomized, evaluator-blind, ...... and skin structure infections
@ast
A randomized, evaluator-blind, ...... and skin structure infections
@en
A randomized, evaluator-blind, ...... and skin structure infections
@nl
prefLabel
A randomized, evaluator-blind, ...... and skin structure infections
@ast
A randomized, evaluator-blind, ...... and skin structure infections
@en
A randomized, evaluator-blind, ...... and skin structure infections
@nl
P2093
P356
P1476
A randomized, evaluator-blind, ...... and skin structure infections
@en
P2093
Gary J Noel
Howard Hait
Michael P Draper
Robert D Arbeit
S Ken Tanaka
P304
P356
10.1128/AAC.00948-12
P407
P577
2012-08-20T00:00:00Z